Gregor Larbig
Impact in
- Physiology top 10%
- Alzheimer's disease research and treatments
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Alzheimer's disease research and treatments 7
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Boris Schmidt (6 shared papers)Marcus Pickhardt (3 shared papers)Alexander S. S. Dömling (2 shared papers)Barbara Beck (2 shared papers)Bernd Meyer (1 shared paper)Inna Khlistunova (2 shared papers)Eva‐Maria Mandelkow (2 shared papers)Eckhard Mandelkow� (1 shared paper)
- Journals
- Bioconjugate Chemistry (2 papers)Current Alzheimer Research (1 paper)Current Topics in Medicinal Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Helvetica Chimica Acta (1 paper)
- Partner nations
- Germany
In The Last Decade
Gregor Larbig
11 papers receiving 424 citations
Peers
Comparison fields: 5 of 39
- Physiology 200
- Biomaterials 61
- Organic Chemistry 103
- Nephrology 20
- Pharmacology 30
Countries citing papers authored by Gregor Larbig
This map shows the geographic impact of Gregor Larbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Larbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Larbig more than expected).
Fields of papers citing papers by Gregor Larbig
This network shows the impact of papers produced by Gregor Larbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Larbig. The network helps show where Gregor Larbig may publish in the future.
Co-authors
The 21 scholars most cited alongside Gregor Larbig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 108 | |
| 2 | 2003 | 91 | |
| 3 | 2016 | 82 | |
| 4 | 2007 | 52 | |
| 5 | 2006 | 44 | |
| 6 | 2016 | 26 | |
| 7 | 2006 | 19 | |
| 8 | 2006 | 13 | |
| 9 | 2006 | 9 | |
| 10 | 2004 | 5 | |
| 11 | 2022 | 2 | |
| 12 | Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells and Directives for Drug Development | 2007 | 1 |
About Gregor Larbig
Gregor Larbig is a scholar working on Physiology, Biomaterials, Pharmaceutical Science, Polymers and Plastics and Hematology, having authored 12 papers that have together received 452 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), RNA Interference and Gene Delivery (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Erythropoietin and Anemia Treatment (1 paper), Chemical Synthesis and Analysis (1 paper), Advanced Drug Delivery Systems (1 paper), Electronic Packaging and Soldering Technologies (1 paper) and Multicomponent Synthesis of Heterocycles (1 paper). The work is most often cited by research in Physiology (200 citations), Biomaterials (61 citations), Organic Chemistry (103 citations), Nephrology (20 citations) and Pharmacology (30 citations). Gregor Larbig has collaborated with scholars based in Germany. Frequent co-authors include Boris Schmidt, Marcus Pickhardt, Alexander S. S. Dömling, Barbara Beck, Bernd Meyer, Inna Khlistunova, Eva‐Maria Mandelkow, Eckhard Mandelkow�, Uwe Haberkorn and Eberhardt Herdtweck. Their work appears in journals such as Bioconjugate Chemistry, Current Alzheimer Research, Current Topics in Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.